Novel precision fermentation process to produce animal-free bioidentical ovalbumin

Onego Bio aims to revolutionize the egg market by producing animal-free ovalbumin through precision fermentation, ensuring cost parity and reduced environmental impact while enhancing food security.

Subsidie
€ 2.499.999
2025

Projectdetails

Introduction

Eggs are critically important in the global food system due to their functional and nutritional properties. However, the egg market and supply chains are currently in crisis due to cage-free requirements and avian flu.

Onego Bio's Solution

Onego Bio will make it possible to manufacture egg protein entirely animal-free. We have developed a highly scalable precision fermentation process using the patented Trichoderma reesei cellular-based production to produce animal-free ovalbumin.

Environmental Impact

We produce bioidentical egg protein with:

  • Cost parity
  • 87% lower CO2 emissions compared to traditional animal-derived eggs

Importance of Ovalbumin

Ovalbumin is the most important egg protein, responsible for essential ingredient performance. This single protein can solve all current challenges in the egg market and supply chain.

Product Overview

Our product, Bioalbumen, provides the nutritional and functional upsides of egg protein without the environmental, ethical, and safety-related drawbacks.

Benefits of Bioalbumen

  • Stabilizes the food supply chain
  • Increases food security

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.499.999
Totale projectbegroting€ 2.499.999

Tijdlijn

Startdatum1-1-2025
Einddatum31-12-2026
Subsidiejaar2025

Partners & Locaties

Projectpartners

  • ONEGO BIO LTDpenvoerder

Land(en)

Finland

Vergelijkbare projecten binnen EIC Accelerator

EIC Accelerator

A new cardioprotective drug for acute treatment of myocardial infarction

ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.

€ 2.499.999
EIC Accelerator

"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""

NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes.

€ 2.306.500
EIC Accelerator

Autonomous robotics and digital TWIN to improve water network performances

The project develops a robotic inspection system for water utilities, enabling autonomous pipeline assessments to enhance water quality and sustainability through a subscription-based RaaS model.

€ 2.478.210
EIC Accelerator

Toopi Regen: Unleash the power of urine to finally scale a real closed loop and regenerative farming system

Toopi Organics aims to revolutionize agriculture by up-cycling human urine into sustainable biostimulants, reducing reliance on mineral fertilizers while enhancing soil health and farmer profitability.

€ 2.396.457

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Synthetic proteins for sustainable animal feeding

SYNFEED aims to revolutionize animal feeding by developing sustainable, digestible proteins through precision nutrition and biosynthesis, reducing environmental impact and EU dependency on imports.

€ 3.079.962
MIT Haalbaarheid

High-throughput geslachtsbepaling van kippeneieren

In Ovo onderzoekt een innovatie voor snellere geslachtsbepaling van kippeneierembryo's om de efficiëntie en dierenwelzijn in de pluimveehouderij te verbeteren.

€ 20.000
MIT Haalbaarheid

Plantaardig ei o.b.v. kikkererwten

Kipster onderzoekt de haalbaarheid van een plantaardige ei-vervanger op basis van kikkererwten, gericht op voedselveiligheid, houdbaarheid en schaalbare productie.

€ 20.000
MIT Haalbaarheid

Plantaardig ei o.b.v. kikkererwten

Kipster onderzoekt de haalbaarheid van een plantaardig ei op basis van kikkererwten, gericht op voedselveiligheid en productieprocessen.

€ 20.000